Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is Japan’s oldest and largest full-service pre-clinical CRO. SNBL is especially experienced in NHP DART studies as well as other regulatory driven safety and pharmacology studies. With wide variety of imaging modalities, discovery and efficacy studies can be also supported. SNBL is a leader in the 3Rs in Asia.
We are ready to support your drug or medical device development in our GLP facilities.